These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 2013207

  • 1. Comparative in vitro antifungal susceptibility studies with 30 serotype A and B isolates of Candida albicans.
    Shadomy S, Shadomy HJ.
    Diagn Microbiol Infect Dis; 1991; 14(1):21-2. PubMed ID: 2013207
    [Abstract] [Full Text] [Related]

  • 2. In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species.
    Smith KR, Lank KM, Dismukes WE, Cobbs CG.
    Eur J Clin Microbiol Infect Dis; 1991 Jul; 10(7):588-92. PubMed ID: 1655435
    [Abstract] [Full Text] [Related]

  • 3. The effect of cilofungin (LY 121019) in combination with amphotericin B or flucytosine against Candida species.
    Bulo AN, Bradley SF, Kauffman CA.
    Mycoses; 1989 Mar; 32(3):151-7. PubMed ID: 2733727
    [Abstract] [Full Text] [Related]

  • 4. The effect of cilofungin (LY 121019) in combination with amphotericin B or flucytosine against Candida species.
    Bulo AN, Bradley SF, Kauffman CA.
    Mycoses; 1989 Jan; 32(1):46-52. PubMed ID: 2747742
    [Abstract] [Full Text] [Related]

  • 5. In-vitro activity of cilofungin (LY121019) in comparison with amphotericin B.
    Meunier F, Lambert C, Van der Auwera P.
    J Antimicrob Chemother; 1989 Sep; 24(3):325-31. PubMed ID: 2681118
    [Abstract] [Full Text] [Related]

  • 6. Effect of cilofungin on phagocytosis and intracellular killing of Candida albicans by human neutrophils.
    Richardson MD, Scott G, Shankland GS.
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):22-6. PubMed ID: 1563379
    [Abstract] [Full Text] [Related]

  • 7. [Assessment of the sensitivity to antifungal agents of clinical isolates of Candida albicans serotype A and B by the ATB Fungus method].
    Quindós G, San Millán R, Burgos A, Lipperheide V, Tellaetxe M, Alonso R, Barturen B, Pontón J.
    Enferm Infecc Microbiol Clin; 1995 Apr; 13(4):209-12. PubMed ID: 7779872
    [Abstract] [Full Text] [Related]

  • 8. In vitro susceptibility of Candida albicans, Austria 1992.
    Allerberger F, Fassl A, Niederwieser D, Zangerle R, Lingnau W, Dierich MP.
    Mycoses; 1993 Apr; 36(11-12):411-6. PubMed ID: 7935573
    [Abstract] [Full Text] [Related]

  • 9. [Antifungal susceptibility of clinically isolated Candida albicans by broth microdilution method].
    Yamazumi T, Kuroda T, Ohata T, Obana Y, Furuta I.
    Kansenshogaku Zasshi; 1998 Aug; 72(8):813-9. PubMed ID: 9780584
    [Abstract] [Full Text] [Related]

  • 10. Comparative in vitro activity of LY121019 and amphotericin B against clinical isolates of Candida species.
    Spitzer ED, Travis SJ, Kobayashi GS.
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):80-1. PubMed ID: 3132386
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility of nosocomial isolates of Candida species to LY121019 and other antifungal agents.
    Pfaller MA, Wey S, Gerarden T, Houston A, Wenzel RP.
    Diagn Microbiol Infect Dis; 1989 Feb; 12(1):1-4. PubMed ID: 2714066
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates.
    Martinez-Suarez JV, Rodriguez-Tudela JL.
    Antimicrob Agents Chemother; 1996 May; 40(5):1277-9. PubMed ID: 8723483
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
    Hernández Molina JM, Llosá J, Martinez Brocal A, Ventosa A.
    Mycopathologia; 1992 Apr; 118(1):15-21. PubMed ID: 1406898
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology.
    Keele DJ, DeLallo VC, Lewis RE, Ernst EJ, Klepser ME.
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):121-6. PubMed ID: 11750164
    [Abstract] [Full Text] [Related]

  • 18. Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis.
    Hall GS, Myles C, Pratt KJ, Washington JA.
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1331-5. PubMed ID: 3058017
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of in vitro antifungal activity of LY121019.
    Hobbs M, Perfect J, Durack D.
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):77-80. PubMed ID: 3132385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.